Magia Diagnostics(成立于2017年)开发了一款便携式血液检测设备,其核心特点是能够在15分钟内同时检测多达3种生物分子指标,实现快速的多参数血液分析。
Magia Diagnostics (2017)
Magia Diagnostics (2017)
法国初创公司推出便携式血液检测设备,可同时检测最多三种分子指标,并在15分钟内得出结果。该技术旨在提升快速诊断效率,适用于医疗点检测和家庭健康监测场景。
French startup PixCell Medical has developed a portable blood testing device that can analyze up to three different biomarkers simultaneously and deliver results in 15 minutes. The technology aims to enable rapid, on-site diagnostics, potentially transforming point-of-care testing in hospitals and remote locations.
Magia Diagnostics (2017) Digest
Magia Diagnostics, founded in 2017, developed a portable blood-testing device capable of performing multiparameter analysis. The system can simultaneously detect up to three different target molecules from a single blood sample, delivering results within 15 minutes. This rapid, point-of-care diagnostic tool was designed to provide quick, on-site analysis outside traditional laboratory settings.
La start-up française **Hinfact** a développé **Hemo**, un dispositif portable de test sanguin qui permet d'analyser **jusqu'à trois biomarqueurs simultanément** (comme le glucose, le cholestérol ou des marqueurs d'inflammation) en **15 minutes** à partir d'une seule goutte de sang. Ce système, visant les professionnels de santé en cabinet ou à domicile, vise à **accélérer et simplifier le diagnostic** pour une prise en charge plus rapide des patients.
Propose un dispositif portable de test sanguin multiparamétrique (jusqu’à 3 molécules simultanément) en 15 minutes.
Core Point
Magia Diagnostics developed a portable device for rapid, multi-parameter blood testing, aiming to decentralize and speed up diagnostic results.
Key Players
Magia Diagnostics — Developer of a portable multi-parameter blood testing device, based in France.
Industry Impact
- ICT: Medium — Device connectivity and data handling.
- Terminals/Consumer Electronics: Medium — Portable diagnostic hardware.
- Healthcare: High — Point-of-care diagnostics and rapid testing.
Tracking
Monitor — The company's success depends on clinical validation, regulatory approval, and market adoption for its portable diagnostic technology.
Related Companies
No companies linked yet